PMID- 22202101 OWN - NLM STAT- MEDLINE DCOM- 20130805 LR - 20240504 IS - 1945-0524 (Electronic) IS - 1945-0516 (Print) IS - 1945-0516 (Linking) VI - 4 IP - 3 DP - 2012 Jan 1 TI - The role of mTOR signaling in Alzheimer disease. PG - 941-52 AB - The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of rapamycin (mTOR) may play a role in Abeta and tau induced neurodegeneration. FAU - Oddo, Salvatore AU - Oddo S AD - Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. oddo@uthscsa.edu LA - eng GR - K99 AG029729/AG/NIA NIH HHS/United States GR - RC2AG036613/AG/NIA NIH HHS/United States GR - RC2 AG036613/AG/NIA NIH HHS/United States GR - K99/R00 AG29729-4/AG/NIA NIH HHS/United States GR - R00 AG029729/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20120101 PL - Singapore TA - Front Biosci (Schol Ed) JT - Frontiers in bioscience (Scholar edition) JID - 101485241 RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Alzheimer Disease/*metabolism MH - Animals MH - Humans MH - Signal Transduction MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC4111148 MID - NIHMS606146 EDAT- 2011/12/29 06:00 MHDA- 2013/08/06 06:00 PMCR- 2014/07/25 CRDT- 2011/12/29 06:00 PHST- 2011/12/29 06:00 [entrez] PHST- 2011/12/29 06:00 [pubmed] PHST- 2013/08/06 06:00 [medline] PHST- 2014/07/25 00:00 [pmc-release] AID - 310 [pii] AID - 10.2741/s310 [doi] PST - epublish SO - Front Biosci (Schol Ed). 2012 Jan 1;4(3):941-52. doi: 10.2741/s310.